Engelhardt W, Gorczytza H, Butterweck A, Mönkemann H, Frey J
Universität Bielefeld, Fakultät für Chemie-Biochemie II, Bielefeld, FRG.
Eur J Immunol. 1991 Sep;21(9):2227-38. doi: 10.1002/eji.1830210934.
Two isotypes of the monocyte/macrophage as well as B cell Fc gamma receptor type II (FcRIIa and FcRIIb2, respectively) mainly differ in the length (76 vs. 44 amino acids) and amino acid sequence of their cytoplasmic domains. Only the eight amino acids just behind the putative transmembrane region are identical. Despite this marked difference, both FcRII mediate endocytosis of immune complexes. To determine the functional significance of the cytoplasmic domains, we expressed truncated FcRIIa and FcRIIb2 in FcR- BHK-21 cells. Mutants of both receptors containing only one amino acid (tail-minus) of the cytoplasmic domain failed to mediate immune complex uptake. The significance of the cytoplasmic domain of the receptors could be further demonstrated using a chimeric FcRIII-FcRIIa construct. Therefore we expressed an FcRIII lacking the hydrophobic carboxyl terminus (containing the putative phosphatidyl - inositol - glycan anchor site) fused inframe to the transmembrane and cytoplasmic domain of the FcRIIa in BHK-21 cells. In contrast to the wild type FcRIII, this chimeric receptor mediated immune complex uptake indistinguishable from that mediated by the FcRIIa. Receptor mutants with relatively short cytoplasmic domains (FcRIIb2: 13, and FcRIIa: 16 amino acids) revealed, that these short amino acid stretches are sufficient to allow reduced receptor-mediated endocytosis of bound ligand. Furthermore, using FcRIIa deletion mutants with a cytoplasmic domain consisting of 62, 46, and 28 amino acids, respectively, we found that the capability of these mutants to mediate immune complex uptake decreased gradually with the truncation of the cytoplasmic tails. Thus, only short amino acid sequences of the cytoplasmic domain are sufficient to enable an, albeit reduced, receptor-mediated endocytosis.
单核细胞/巨噬细胞以及B细胞的两种免疫球蛋白同种型II型Fcγ受体(分别为FcRIIa和FcRIIb2)主要在其胞质结构域的长度(76个氨基酸对44个氨基酸)和氨基酸序列上有所不同。仅推定跨膜区域之后的八个氨基酸是相同的。尽管存在这种显著差异,但两种FcRII都介导免疫复合物的内吞作用。为了确定胞质结构域的功能意义,我们在FcR-BHK-21细胞中表达了截短的FcRIIa和FcRIIb2。两种受体仅含有胞质结构域一个氨基酸(无尾)的突变体均无法介导免疫复合物的摄取。使用嵌合的FcRIII-FcRIIa构建体可以进一步证明受体胞质结构域的重要性。因此,我们在BHK-21细胞中表达了一种缺失疏水羧基末端(包含推定的磷脂酰肌醇聚糖锚定位点)的FcRIII,其与FcRIIa的跨膜和胞质结构域读框融合。与野生型FcRIII不同,这种嵌合受体介导的免疫复合物摄取与FcRIIa介导的无法区分。具有相对较短胞质结构域(FcRIIb2为13个氨基酸,FcRIIa为16个氨基酸)的受体突变体表明,这些短氨基酸片段足以使结合配体的受体介导的内吞作用减弱。此外,使用分别具有由62、46和28个氨基酸组成的胞质结构域的FcRIIa缺失突变体,我们发现这些突变体介导免疫复合物摄取的能力随着胞质尾巴的截短而逐渐降低。因此,胞质结构域仅短的氨基酸序列就足以实现尽管减弱但仍由受体介导的内吞作用。